Exercise as a Tool to Protect Brain Health in Parkinson’s Disease
Exercise as a Tool to Protect Brain Health in Parkinson’s Disease
MOVE-BRAIN-PD: A new European project involving […]
Promises, hopes, and dreams in Parkinson’s disease research
Since James Parkinson first described his eponymous disease, our knowledge of its pathophysiology has grown enormously. However, in […]
Lead as an environmental toxicant in models of synucleinopathies
Lead, a toxic heavy metal, is prevalent in various industrial applications, contributing to environmental contamination and significant health […]
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features
Parkinson’s disease (PD) affects millions of people worldwide, but only 5–10% of patients suffer from a monogenic forms […]
Lecture Prof. Evangelia Emmanouilidou
The inhibition of α-synuclein aggregation using marine-derived bacterial metabolites as a novel neuroprotective approach for Parkinson’s Disease
Prof. […]
Exact mechanisms of heat shock–induced lifespan extension, although documented across species, are still not well understood. Here, we show […]
Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
Parkinson’s disease (PD) is a common neurodegenerative condition known for typical motor symptoms associated with the loss of dopaminergic […]
A biological classification of Parkinson’s disease: the SynNeurGe research diagnostic criteria.
With the hope that disease-modifying treatments […]
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments.
Advanced glycation end products (AGEs) arise from the Maillard reaction between dicarbonyls and proteins, nucleic acids, or specific lipids. […]
Heat-Net Meeting 2024
It is our great pleasure to invite you to the our Heat-Net Meeting 2024.
Heat-Net Meeting
The […]